Where is AngioSafe located?

AngioSafe is headquartered in San Jose, United States.

How many employees does AngioSafe have?

As of Jan 31, 2026, the latest employee count at AngioSafe is 43.

Is AngioSafe a funded company?

AngioSafe is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does AngioSafe rank among its competitors?

AngioSafe ranks 22nd amongst 127 active competitors, of which 36 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Echopoint Medical, which secured $250K in Nov, 2025.

Who are the top competitors of AngioSafe?

AngioSafe's top competitors include SMT, Aortyx and Terumo Medical. Among them, Echopoint Medical secured the most recent funding round in November, 2025.

AngioSafe - 2026 Company Profile, Team & Competitors

AngioSafe is an unfunded company based in San Jose (United States), founded in 2014 by Mallik Thatipelli and Ram Reddy. It operates as a Developer of devices to improve coronary and peripheral arterial diseases. AngioSafe has not raised any funding yet. The company has 127 active competitors, including 36 funded and 34 that have exited. Its top competitors include companies like SMT, Aortyx and Terumo Medical.

Company Details

Developer of devices to improve coronary and peripheral arterial diseases. The company develops a pipeline of devices that simplify and improve complex interventional algorithms enabling complex coronary and peripheral vascular interventions.

Website: angiosafe.com
Email ID: *****@angiosafe.com

Key Metrics

Founded Year

2014

Location

San Jose, United States

Stage

Unfunded

Ranked

22^nd among 127 active competitors

Employee Count

43 as on Jan 31, 2026

Similar Companies

SMT & 162 more

View AngioSafe's full profile

AngioSafe has not raised any funding rounds yet.

The founders of AngioSafe are Mallik Thatipelli and Ram Reddy.

Here are the details of AngioSafe's key team members:

Mallik Thatipelli: Co-Founder of AngioSafe.
Contact Info: 1 email address
Ram Reddy: Co-Founder of AngioSafe.

View details of AngioSafe's Founder profiles and Board Members

AngioSafe's employee count trend

AngioSafe has 43 employees as of Jan 26. Here is AngioSafe's employee count trend over the years:

Uncover AngioSafe's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of AngioSafe include SMT, Aortyx and Terumo Medical. Here is the list of Top 10 competitors of AngioSafe, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	SMT 1998, Surat (India), Late Stage	Manufacturer of minimally invasive cardiovascular devices including coronary and structural heart	$93.5M	Samara Capital, Kotak Mahindra Bank & 104 others	71/100
2nd	Aortyx 2018, Barcelona (Spain), Series A	Developer of smart devices for aortic diseases	$15.8M	Clave, EIT Health & 8 others	55/100
3rd	Terumo Medical 1921, Shibuya (Japan), Funding Raised	Provider of a portfolio of medical devices for interventional cardiology	-	BCM Technologies, USAGov	54/100
4th	OpSens 2003, Quebec City (Canada), Acquired	Manufacturer of optical sensors	-	National Research Council Canada, Lumira Ventures ... & 1 others	54/100
5th	Relisys Medical Devices 1997, Ranga Reddy (India), Early Stage	Provider of medical devices for cardiovascular and structural heart treatment	$21.2M	India Life Sciences Fund II, InvAscent & 44 others	53/100
6th	Medyria 2012, Winterthur (Switzerland), Series B	Developer of technology for endovascular catheter navigation and sensing	$12.3M	Verve Ventures, Yellowstone Holding & 9 others	52/100
7th	Echopoint Medical 2018, London (United Kingdom), Series A	Developer of smart devices for monitoring coronary artery disease and microvascular dysfunction	$9.99M	Parkwalk, UCL Technology Fund & 3 others	51/100
8th	Cardiovascular Systems 1989, Saint Paul (United States), Acquired	Developer of devices for treating peripheral and coronary vascular disease	$121M	Maverick Ventures, Mitsui Global Investment ... & 6 others	50/100
9th	iHeart 2013, Kyoto (Japan), Series D	Experts in regenerative medicine	$5.44M	Japan Asia Investment, Mitsui Sumitomo Insurance ... & 5 others	50/100
10th	Vascular Solutions 1997, Minneapolis (United States), Acquired	Products for vascular diagnostics and interventional procedures	$12M	SpringRock Ventures, The Stephens Group & 3 others	50/100
22nd	AngioSafe 2014, San Jose (United States), Unfunded	Developer of devices to improve coronary and peripheral arterial diseases	-	-	42/100